Where does Natus Medical Incorporated rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Natus Medical Incorporated ranks #12,580 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Natus Medical Incorporated hold?

Natus Medical Incorporated holds 24 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Natus Medical Incorporated's Innovation Score?

Natus Medical Incorporated has an Innovation Score of 39.6 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Natus Medical Incorporated focus on?

Natus Medical Incorporated's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 23 patents, ranking #784 of 7,127 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Natus Medical Incorporated's patent grant rate increasing or decreasing?

Natus Medical Incorporated's recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Natus Medical Incorporated's patents?

Natus Medical Incorporated's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Natus Medical Incorporated patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Natus Medical Incorporated

USPTO PatentsView assignee record - 24 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Natus ranks #12,580 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 11 technology areas.

#12,580
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.6/100): 18.5
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12580 · US Corporation #12,580 · 24 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 24 grants
MID-PACK #12,580/49,997
PHOTO-FINISH Nanchang Coolpad…
CPC-FOCUS A61B · 11 areas
INNOV-THIN 39.6/100
CLAIMS-RICH 18.5 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nanchang Coolpad Intelligent Technology Company Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Natus’s 39.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (28%) Velocity 5.7 pts (14%) Breadth 11.7 pts (30%) Claim depth 11.1 pts (28%)

Qualcomm Incorporated · highest

85
Natus Medical… · this assignee

40
Palliare · near

40
PointSource · near

40
Taiwan FU Hsing… · near

40
Vaccinex · near

40
3D Lighting… · lowest

7

What this shows Natus's Innovation Score is 39.6/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Natus?

Each dot is one of Natus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Natus’s own 18.5 claims/patent is ABOVE the 9.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Natus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Natus's grants concentrate

Natus Medical Incorporated is a focused PatentsView assignee: 11 CPC subclasses with 95.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2020. By volume, Natus sits between NOV Downhole Eurasia Limited and Nemo Equipment, Inc..

Natus's three-year grant acceleration

Natus Medical Incorporated shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

NOV Downhole Eura…

24
NS Materials

24
Nanchang Coolpad…

24
Nanchang Hangkong…

24
Navitar Industries

24
Neonc

24
Nemak B de C V

24
Nemo Equipment

24
Natus Medical Inc… ◀

24

What this shows Natus holds 24 patents at rank #12,591, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Natus

By rank, the assignees closest to #12,591 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Natus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Natus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Natus ranks #784 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Vaccinex, Inc. 40 Taiwan FU Hsing Industrial Co., Ltd. 40 PointSource Technologies, LLC 40 Palliare Limited 40

Natus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Natus Medical Incorporated patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	12.5%
2017	3	12.5%
2018	3	12.5%
2019	3	12.5%
2020	1	4.2%
2021	3	12.5%
2022	1	4.2%
2023	2	8.3%
2024	3	12.5%
2025partial year	2	8.3%

Which technologies does Natus Medical Incorporated patent most?

A61B - DIAGNOSIS; SURGERY; Identification 23

G02B - Optical Elements, Systems OR Apparatus 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 2

G06F - Electric Digital Data Processing 1

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

H04B - Transmission 1

G06V - Image OR Video Recognition OR Understanding 1

G06T - Image Data Processing OR Generation, IN General 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Natus Medical Incorporated's patent record in context - here's where to go next.

Natus Medical Incorporated's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95.8% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #12,580 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Natus Medical Incorporated against NOV Downhole Eurasia Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.